Congenital malformations of the circulatory system

Q17_CONGEN_MALFO_CIRCULATO_SYSTEM

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q20-Q28 Cause of death: ICD-10 — Q20-Q28 2 out of 7 registries used, show all original rules.	6074
4. Check minimum number of events None	6074
5. Include endpoints Q17_CONGEN_MALFO_CARDIAC_CHAMB_CONNECTIO Q17_CONGEN_MALFO_CARDIAC_SEPTA Q17_CONGEN_MALFO_PULMONARY_TRICU_VALVES Q17_CONGEN_MALFO_AORTIC_MITRAL_VALVES Q17_OTHER_CONGEN_MALFO_HEART Q17_CONGEN_MALFO_GREAT_ARTERIES Q17_CONGEN_MALFO_GREAT_VEINS Q17_OTHER_CONGEN_MALFO_PERIP_VASCULAR_SYSTEM Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM	6182
6. Filter based on genotype QC (FinnGen only)	6182

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Q
Name in latin: Malformationes congenitae systematis circulatorii

NAME	Q17_CONGEN_MALFO_CIRCULATO_SYSTEM
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	Q17_CONGEN_MALFO_CARDIAC_CHAMB_CONNECTIO\|Q17_CONGEN_MALFO_CARDIAC_SEPTA\|Q17_CONGEN_MALFO_PULMONARY_TRICU_VALVES\|Q17_CONGEN_MALFO_AORTIC_MITRAL_VALVES\|Q17_OTHER_CONGEN_MALFO_HEART\|Q17_CONGEN_MALFO_GREAT_ARTERIES\|Q17_CONGEN_MALFO_GREAT_VEINS\|Q17_OTHER_CONGEN_MALFO_PERIP_VASCULAR_SYSTEM\|Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q2
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q2
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Congenital malformations of the circulatory system based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	67904	34160	33569
Only index persons	48626	24424	24202
Unadjusted period prevalence (%)
Whole population	0.96	0.98	0.94
Only index persons	0.91	0.90	0.92
Median age at first event (years)
Whole population	4.83	4.35	5.11
Only index persons	16.90	17.34	16.45

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6182	3265	2917
Unadjusted period prevalence (%)	1.19	1.11	1.29
Median age at first event (years)	44.81	40.53	49.59

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5261: Matched controls
51722

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q23.11

ICD-10 Finland

Bicuspid aortic valve

1437.3

323.0

1146

FFC22

NOMESCO Finland

Percutaneous transluminal closure of ostium secundum type ASD

+∞

323.0

336

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

6.6

323.0

1855

3956

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

16.2

323.0

1395

1125

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

+∞

323.0

338

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

15.5

323.0

800

590

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

+∞

323.0

401

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

+∞

323.0

440

Q21.10

ICD-10 Finland

Persistent ostium secundum

+∞

323.0

654

Q21.19

ICD-10 Finland

Atrial septal defect NOS

+∞

323.0

378

B01AA03

ATC

warfarin; systemic

5.4

323.0

1555

3727

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

5.9

323.0

2129

5302

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

2309.8

323.0

654

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

12.5

323.0

800

732

I35.0

ICD-10 Finland

Aortic (valve) stenosis

10.0

313.5

667

742

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

+∞

312.8

299

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

+∞

311.7

298

Q25.1

ICD-10 Finland

Coarctation of aorta

2894.8

299.8

289

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

14.9

297.2

517

376

XF620

NOMESCO Finland

Examination of circulation with color method

107.1

271.4

298

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

17.0

261.2

429

268

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

17.1

248.0

407

253

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

245.2

2556

13340

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.9

242.2

1170

3544

XF404

NOMESCO Finland

Ambulatory ECG

4.8

228.6

849

1991

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.4

224.1

1305

4566

Q25.0

ICD-10 Finland

Patent ductus arteriosus

+∞

222.1

213

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

4.8

215.9

807

1897

XF400

NOMESCO Finland

ECG with 12 standard connections

3.4

212.3

1208

4132

WX872

NOMESCO Finland

Intensive care

6.8

211.9

571

904

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

35.7

210.6

276

201

Kela drug reimbursment

Chronic cardiac insufficiency

8.2

204.0

485

636

Congenital heart failure surgery

1888.0

200.9

195

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

18.7

185.2

293

163

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

15.2

165.9

284

194

FFC00

NOMESCO Finland

Suture of ostium secundum type ASD

+∞

165.5

159

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

161.6

1761

8835

C07AB07

ATC

bisoprolol; oral

2.3

156.6

2231

12729

Q27.3

ICD-10 Finland

Peripheral arteriovenous malformation

1554.5

153.9

150

Q22.1

ICD-10 Finland

Congenital pulmonary valve stenosis

+∞

149.8

144

Q27.4

ICD-10 Finland

Congenital phlebectasia

+∞

143.5

138

XF402

NOMESCO Finland

ECG with work load test

3.5

143.5

750

2334

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

4.1

138.8

593

1551

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.4

138.6

549

1337

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

9.3

137.6

299

333

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

4.9

135.5

474

1015

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.8

135.2

1041

4224

FM2CE

NOMESCO Finland

13.3

129.7

234

180

Q21.0

ICD-10 Finland

Ventricular septal defect

+∞

125.7

121

AA1AD

NOMESCO Finland

CT of head and brain

2.4

122.5

1243

5855

7455A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect

+∞

119.5

115

Q21.30

ICD-10 Finland

Tetralogy of Fallot

+∞

118.4

114

Q23.0

ICD-10 Finland

Congenital stenosis of aortic valve

+∞

117.4

113

C03CA01

ATC

furosemide; systemic

2.4

116.6

1196

5643

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

14.0

112.4

198

144

Q23.10

ICD-10 Finland

Congenital insufficiency of aortic valve

1092.9

111.2

109

K83

ICPC

Heart valve disease NOS

16.4

111.0

183

113

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

10.4

110.3

224

220

Q21.9

ICD-10 Finland

Congenital malformation of cardiac septum, unspecified

+∞

109.0

105

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

13.8

109.0

193

142

R4110

NOMESCO Finland

Physiotherapy

2.1

105.3

1503

8215

Catheterization and pressure measurement of the right side of the heart

39.8

105.1

134

74639

ICD-8 Finland

Congenital anomalies of heart, Defectus septi ventriculorum

159.2

104.9

111

TFP20

NOMESCO Finland

Cardiodefibrillation

3.8

100.1

460

1269

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

100.4

99.6

110

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

48.6

98.8

121

C01AA05

ATC

digoxin; systemic

4.1

97.3

405

1023

Catheterization and pressure measurement of the left side of the heart

10.8

96.3

191

179

Q20.3

ICD-10 Finland

Discordant ventriculoarterial connection

+∞

95.5

XA800

NOMESCO Finland

Neuropsychological investigation

3.9

93.5

417

1119

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

93.4

1229

6427

Q27.9

ICD-10 Finland

Congenital malformation of peripheral vascular system, unspecified

+∞

93.4

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

4.2

93.0

377

928

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.4

92.4

355

829

FFC42

NOMESCO Finland

Percutaneous closure of patent foramen ovale

+∞

92.4

PD5BD

NOMESCO Finland

Extensive CT of aorta

8.3

91.9

212

260

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

88.5

617

2304

74719

ICD-8 Finland

Other congenital anomalies of circulatory system, Coarctation of aorta

302.3

88.4

XF640

NOMESCO Finland

6.4

87.9

243

389

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

87.2

904

4216

XFE00

NOMESCO Finland

Epicardial ultrasonography

6.6

87.0

236

368

B01AB05

ATC

enoxaparin; parenteral

2.0

85.9

1417

8089

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

5.3

85.2

273

525

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

4.8

85.1

304

659

FCA50

NOMESCO Finland

Resection and reconstruction of ascending aorta using tube graft

33.1

84.4

112

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

20.1

83.8

128

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.0

83.2

531

1870

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

11.5

78.9

151

132

Q21.18

ICD-10 Finland

Other spedified atrial septal defect

+∞

78.8

WX892

NOMESCO Finland

Monitored bed care

3.0

77.9

488

1695

C03DA01

ATC

spironolactone; oral

2.8

77.5

539

2002

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

28.2

75.4

104

Q27.88

ICD-10 Finland

Other specified congenital malformation of peripheral vascular system

+∞

73.6

XF622

NOMESCO Finland

Measurement of minute volume of heart

36.6

73.4

5205

FHL

ASD blockage, secondary defect

+∞

72.6

207

Kela drug reimbursment

Chronic arrhythmias

2.6

72.2

605

2505

7471A

ICD-9 Finland

Other congenital anomalies of circulatory system, Coarctation of aorta[COARCTATIO AORTAE]

+∞

70.5

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

351.0

70.3

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

4.8

67.1

236

502

D18.0

ICD-10 Finland

Haemangioma, any site

5.5

67.0

208

385

Q28.8

ICD-10 Finland

Other specified congenital malformations of circulatory system

+∞

66.4

XF600

NOMESCO Finland

Bloodpressure measurement

2.9

65.5

434

1557

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

64.8

526

2133

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

63.3

517

2101

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

19.4

63.0

I37.1

ICD-10 Finland

Pulmonary valve insufficiency

215.6

62.8

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

62.2

1035

5817

AF1

Surgery of congenital heart defect

+∞

62.2

PA2AE

NOMESCO Finland

Ultrasound examination of brain artery

70.6

61.8

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

96.8

61.5

C01BD01

ATC

amiodarone; systemic

5.5

61.5

191

354

WX402

NOMESCO Finland

General anaesthesia

2.0

60.6

933

5084

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

10.5

60.4

121

116

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

11.0

59.9

117

107

74642

ICD-8 Finland

Congenital anomalies of heart, Defectus septi atriorum, ostium secundum

50.5

58.6

Q21.20

ICD-10 Finland

Atrial septal defect of primum type

+∞

58.1

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

15.4

57.9

FXA10

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure

121.3

56.5

K78

ICPC

Atrial fibrillation/flutter

3.0

56.5

345

1170

I50.9

ICD-10 Finland

Heart failure, unspecified

2.5

56.4

483

2010

K84

ICPC

Heart disease other

5.2

55.5

180

351

J01CA04

ATC

amoxicillin; systemic

1.7

54.2

4299

37247

C09AA05

ATC

ramipril; oral

1.9

53.3

964

5543

74629

ICD-8 Finland

Congenital anomalies of heart, Tetralogy of Fallot

+∞

52.9

AN1

Coronary angiography

2.4

52.8

486

2097

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

51.0

1058

6361

5253

FHL

Cardiac lung machine

15.1

51.0

Q24.6

ICD-10 Finland

Congenital heart block

+∞

50.8

Q21.21

ICD-10 Finland

Atrioventricular duct

+∞

50.8

7454B

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM SIMPLEX]

253.5

49.8

5255

FHL

Deep hypothermia (<20 °) with cardiopulmonary resuscitation

+∞

49.7

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.7

48.6

222

605

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.7

48.0

342

1280

WX882

NOMESCO Finland

High dependency care

3.4

47.9

249

752

Q21.1

ICD-10 Finland

Atrial septal defect

+∞

47.7

I37.0

ICD-10 Finland

Pulmonary valve stenosis

76.7

47.6

I34.1

ICD-10 Finland

Mitral (valve) prolapse

4.5

47.5

175

391

AB1

AVR mechanical

18.4

47.4

I44.2

ICD-10 Finland

Atrioventricular block, complete

5.3

47.3

149

281

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

5.4

47.3

147

273

PA2JT

NOMESCO Finland

Very extensive embolisation of arterio-venous malformation of the brain

+∞

46.6

Q20.1

ICD-10 Finland

Double outlet right ventricle

+∞

46.6

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

4.0

46.5

196

498

APK

ASD closure

+∞

45.6

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

8.9

45.0

110

Q24.4

ICD-10 Finland

Congenital subaortic stenosis

+∞

44.6

FFC50

NOMESCO Finland

Closure of ostium secundum type ASD using patch

+∞

44.6

R06.0

ICD-10 Finland

Dyspnoea

1.7

44.5

1060

6619

R4150

NOMESCO Finland

Neuropsychological rehabilitation

8.6

44.1

114

PA2HT

NOMESCO Finland

Extensive embolisation of arterio-venous malformation of the brain

433.9

44.0

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.9

43.5

277

965

Q25.3

ICD-10 Finland

Stenosis of aorta

413.9

41.9

PD5BG

NOMESCO Finland

MRI examination of thoracal and abdominal aortta with high intensity magnet

35.7

41.8

APJ

PFO closure

+∞

41.4

Q20.48

ICD-10 Finland

Single ventricle

+∞

41.4

Q23.4

ICD-10 Finland

Hypoplastic left heart syndrome

+∞

41.4

Q23.3

ICD-10 Finland

Congenital mitral insufficiency

+∞

41.4

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.3

41.1

407

1815

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

40.8

1129

7332

74709

ICD-8 Finland

Other congenital anomalies of circulatory system, Patent ductus arteriosus

89.3

40.5

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

14.3

40.3

C07AB02

ATC

metoprolol; systemic

1.8

39.6

766

4464

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.0

39.4

237

794

Q28.0

ICD-10 Finland

Arteriovenous malformation of precerebral vessels

+∞

39.4

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

8.4

38.8

103

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

38.6

559

2938

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

38.6

2092

15915

Q22.5

ICD-10 Finland

Ebstein anomaly

+∞

38.3

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

10.1

38.1

R4120

NOMESCO Finland

Occupational therapy

2.4

37.9

346

1482

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

25.0

37.6

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

5.0

37.5

123

244

PD5DG

NOMESCO Finland

Very extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

36.6

37.5

AP3

Catheterization of the right and left side of the heart

29.2

37.0

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.5

36.6

310

1278

Q25.48

ICD-10 Finland

Other congenital malformations of the aorta

+∞

36.3

74663

ICD-8 Finland

Congenital anomalies of heart, Stenosis valvulae pulmonalis

53.2

36.1

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

8.6

35.4

I49.5

ICD-10 Finland

Sick sinus syndrome

3.7

35.4

163

448

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

14.5

35.4

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

35.2

1406

9951

7456A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Endocardial cushion defects[DEFECTUS SEPTI ATRIORUM NUD]

+∞

35.2

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.9

34.9

147

374

B01AC04

ATC

clopidogrel; oral

1.9

34.5

558

3046

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

34.5

511

2704

QX3LT

NOMESCO Finland

Subcutaneous sclerotherapy

30.4

34.4

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

34.4

483

2504

FJF10

NOMESCO Finland

Replacement of pulmonary valve using biological prosthesis

+∞

34.2

AP2

Catheterization of the right side of the heart

18.1

34.0

7454A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM NUD]

118.8

33.5

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

6.6

33.2

131

R42

ICD-10 Finland

Dizziness and giddiness

1.7

33.2

855

5405

C10AA05

ATC

atorvastatin; oral

1.5

33.2

1372

9763

FJF20

NOMESCO Finland

Replacement of pulmonary valve using homograft

+∞

33.1

FBE10

NOMESCO Finland

Expansion or reconstruction of pulmonary artery using patch

+∞

33.1

PA2GT

NOMESCO Finland

Embolisation of arterio-venous malformation of the brain

+∞

33.1

5207

FHL

VSD closure

+∞

33.1

C07AA07

ATC

sotalol; systemic

3.4

32.5

162

475

Z31.5

ICD-10 Finland

Genetic counselling

2.4

32.3

297

1277

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

4.4

32.1

119

269

I97.0

ICD-10 Finland

Postcardiotomy syndrome

13.6

32.1

FHB50

NOMESCO Finland

Transatrial closure of VSD using patch

+∞

32.1

Q25.40

ICD-10 Finland

Aortic hypoplasia

+∞

32.1

Q26.3

ICD-10 Finland

Partial anomalous pulmonary venous connection

+∞

32.1

Q21.3

ICD-10 Finland

Tetralogy of Fallot

+∞

32.1

Q24.8

ICD-10 Finland

Other specified congenital malformations of heart

+∞

32.1

WX002

NOMESCO Finland

Sedation and analgesia

1.6

31.7

836

5315

FBE35

NOMESCO Finland

Percutaneous transluminal angioplasty of pulmonary artery with insertion of stent

313.6

31.7

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

15.6

31.6

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

12.6

31.2

FDF05

NOMESCO Finland

Percutaneous transluminal occlusion of aorto-pulmonary collaterals

+∞

31.1

Q25.6

ICD-10 Finland

Stenosis of pulmonary artery

+∞

31.1

90492

NOMESCO Finland

52.3

31.0

I47.2

ICD-10 Finland

Ventricular tachycardia

4.1

31.0

123

297

FM1CD

NOMESCO Finland

Very extensive CT of heart

13.8

30.7

H53.4

ICD-10 Finland

Visual field defects

4.0

30.5

125

311

74699

ICD-8 Finland

Congenital anomalies of heart, Unspecified anomalies of heart

158.2

30.5

FCA75

NOMESCO Finland

Valve-sparing repair of aortic root (David, Yacoub)

108.8

30.4

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

20.3

30.1

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

29.9

414

2130

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

4.7

29.6

104

223

I50.0

ICD-10 Finland

Congestive heart failure

2.6

29.6

228

893

FBE32

NOMESCO Finland

Percutaneous transluminal angioplasty of pulmonary artery

105.5

29.5

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.2

29.4

161

507

XX6KT

NOMESCO Finland

Other sclerotherapy

44.5

29.4

N02BE01

ATC

paracetamol; systemic, rectal

1.4

29.3

3963

35065

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

18.6

29.2

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4.0

29.2

121

305

Q22.0

ICD-10 Finland

Pulmonary valve atresia

+∞

29.0

Q24.0

ICD-10 Finland

Dextrocardia

+∞

29.0

7452A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Tetralogy of Fallot[TETRALOGIA FALLOT]

+∞

29.0

Q25.41

ICD-10 Finland

Persistent right-sided aortic arch

+∞

29.0

AJ2

Reconstruction of the ascending aorta

31.3

28.8

TFP34

NOMESCO Finland

Electrophysiological investigation

3.0

28.7

170

563

74619

ICD-8 Finland

Congenital anomalies of heart, Transposition of great vessels

288.5

28.6

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.7

28.4

197

722

R50.9

ICD-10 Finland

Fever, unspecified

1.7

28.4

686

4243

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

16.5

28.1

Angiography of the heart and coronary arteries

2.6

28.0

214

833

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

12.7

28.0

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

6.9

28.0

103

Q28.1

ICD-10 Finland

Other malformations of precerebral vessels

+∞

28.0

7460C

ICD-9 Finland

Other congenital anomalies of heart, Anomalies of pulmonary valve[VITIUM VALVULAE PULMONALIS CONGENITA CUM STENOSIS]

+∞

28.0

WW502

NOMESCO Finland

Autotransfusion

8.1

27.8

AB2

AVR bio, stent

10.7

27.4

R01.1

ICD-10 Finland

Cardiac murmur, unspecified

3.4

27.2

138

411

WZC30

NOMESCO Finland

Teaching

1.7

27.2

572

3393

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

9.3

27.2

RS224

NOMESCO Finland

7.1

27.0

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.0

27.0

112

283

Q28.9

ICD-10 Finland

Congenital malformation of circulatory system, unspecified

+∞

26.9

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

26.1

26.8

Aortic Valve Replacement (AVR)

26.1

26.8

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.5

26.8

223

911

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.6

26.6

196

748

G04BE03

ATC

sildenafil; oral

4.7

26.6

195

K99

ICPC

Cardiovascular disease other

3.7

26.5

120

327

I47.1

ICD-10 Finland

Supraventricular tachycardia

2.5

26.3

217

883

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

18.9

26.2

K90

ICPC

Stroke/cerebrovascular accident

3.5

26.2

128

371

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

9.4

26.0

7AX01

NOMESCO Finland

28.8

26.0

AA5PD

NOMESCO Finland

CT examination of brain pefusion

6.8

26.0

FDA00

NOMESCO Finland

Aortoplasty and aorto-pulmonary shunt for HLHS

+∞

25.9

7451A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Transposition of great vessels[TRANSPOSITIO CORDIS COMPLETA]

+∞

25.9

Q25.78

ICD-10 Finland

Other congenital malformations of pulmonary artery

+∞

25.9

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.2

25.7

280

1304

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.4

25.6

126

368

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

6.1

25.2

115

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.4

25.0

124

364

WX704

NOMESCO Finland

Intubation

2.0

24.9

328

1654

AEX

Other pulmonary or pulmonary artery valve procedure

+∞

24.9

N03AF02

ATC

oxcarbazepine; oral

2.6

24.8

185

712

I37.2

ICD-10 Finland

Pulmonary valve stenosis with insufficiency

247.1

24.5

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

24.5

285

1365

PD5CD

NOMESCO Finland

Very extensive CT angiography of aorta

8.5

24.1

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

10.3

23.9

FAE10

NOMESCO Finland

Bidirectional anastomosis between superior vena cava and pulmonary artery

+∞

23.8

5513

FHL

Coarctation resection, plastic or bypass

+∞

23.8

Q21.32

ICD-10 Finland

Pulmonary atresia with Fallot ventricular septal defect

+∞

23.8

Q26.1

ICD-10 Finland

Persistent left superior vena cava

+∞

23.8

R04.0

ICD-10 Finland

Epistaxis

2.1

23.8

289

1408

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

9.7

23.6

74673

ICD-8 Finland

Congenital anomalies of heart, Stenosis valvulae aortae

236.9

23.5

TFP35

NOMESCO Finland

Electroanatomical mapping

4.3

23.5

203

602

Kela drug reimbursment

Children's severe malnutrition

5.3

23.4

135

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

23.3

275

1326

I77.0

ICD-10 Finland

Arteriovenous fistula, acquired

23.3

23.2

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

23.2

718

4725

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

5.7

22.9

114

Q21.12

ICD-10 Finland

Defective sinus venosus

+∞

22.8

Q24.9

ICD-10 Finland

Congenital malformation of heart, unspecified

+∞

22.8

FXA20

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure

21.8

22.8

ZX199

NOMESCO Finland

Other rote

11.6

22.6

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

22.6

842

5785

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

29.6

22.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

22.5

619

3953

FPF20

NOMESCO Finland

Implantation of epicardial pacemaker with atrial and ventricular electrodes

118.5

22.4

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.7

22.1

161

J01DB01

ATC

cefalexin; oral

1.4

21.9

3956

35567

R51.80

ICD-10 Finland

Headache

1.6

21.8

706

4694

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.2

21.8

117

366

Q21.29

ICD-10 Finland

Atrioventricular septal defect UNS

+∞

21.7

Q21.80

ICD-10 Finland

Communication from left ventricle to right atrium

+∞

21.7

Q23.8

ICD-10 Finland

Other congenital malformations of aortic and mitral valves

+∞

21.7

Q21.81

ICD-10 Finland

Eisenmenger's syndrome

+∞

21.7

Z94.1

ICD-10 Finland

Heart transplant status

11.6

21.7

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

21.6

198

850

FC1BC

NOMESCO Finland

Extensive angiography of thoracal aortta

15.7

21.6

XX4BW

NOMESCO Finland

9.9

21.5

I27.0

ICD-10 Finland

Primary pulmonary hypertension

18.1

21.5

PG1HT

NOMESCO Finland

Extensive endovascular embolisation of arterio-venous malformation not elsewhere classified

217.1

21.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.4

21.3

179

736

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

5.2

21.3

129

FPD10

NOMESCO Finland

Surgical ablation of atrial fibrillation

30.7

21.3

7470A

ICD-9 Finland

Other congenital anomalies of circulatory system, Patent ductus arteriosus

42.8

21.2

F83

ICD-10 Finland

Mixed specific developmental disorders

3.9

21.2

229

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

49.4

20.9

74646

ICD-8 Finland

Congenital anomalies of heart, Defectus septi atriorum, ostium primum

49.4

20.9

XCK00

NOMESCO Finland

Perimetry

2.0

20.9

259

1274

R62.0

ICD-10 Finland

Delayed milestone

3.8

20.8

238

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

20.7

633

4147

FFC32

NOMESCO Finland

Percutaneous transluminal closure of sinus venosus type ASD

+∞

20.7

Q24.3

ICD-10 Finland

Pulmonary infundibular stenosis

+∞

20.7

FAE00

NOMESCO Finland

Anastomosis to pulmonary artery from superior vena cava

+∞

20.7

7463A

ICD-9 Finland

Other congenital anomalies of heart, Congenital stenosis of aortic valve[STENOSIS VALVULAE AORTAE CONGENITA]

108.6

20.4

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

20.3

272

1381

B01AF02

ATC

apixaban; oral

1.9

20.3

302

1593

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

8.5

20.3

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

41.1

20.3

PD5AD

NOMESCO Finland

CT of aorta

3.9

20.0

212

I50.1

ICD-10 Finland

Left ventricular failure

2.5

19.9

156

617

Q21.31

ICD-10 Finland

Tetralogy of Fallot and double outlet right ventricle

+∞

19.7

Q27.0

ICD-10 Finland

Congenital absence and hypoplasia of umbilical artery

+∞

19.7

FDE32

NOMESCO Finland

Percutaneous transluminal closure of patent ductus arteriosus

+∞

19.7

Q22.2

ICD-10 Finland

Congenital pulmonary valve insufficiency

+∞

19.7

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

4.6

19.6

146

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

19.3

1085

8069

I48.4

ICD-10 Finland

Atypical atrial flutter

11.5

19.0

I35.8

ICD-10 Finland

Other aortic valve disorders

11.5

19.0

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

4.7

19.0

134

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

5.2

18.8

110

Q87.14

ICD-10 Finland

Noonan's syndrome

54.3

18.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

18.8

405

2416

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2071

6804

3.94

307.65

3.7

2.7

30.6

29.9

4.87

2041

6616

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2710

10126

3.85

307.65

4.8

3.0

ng/l

964.7

1218.5

2.94

2463

8480

(3032080) INR in Blood by Coagulation assay

3383

16349

3.24

307.65

18.1

7.8

inr

1.6

1.2

54.37

943

4886

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1116

3000

4.18

307.65

3.9

3.0

ng/l

183.6

176.4

0.22

1016

2679

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

869

1769

5.38

307.65

5.1

3.9

92.8

92.9

0.04

840

1668

(3036489) Thrombin time

826

2011

4.44

297.39

3.6

3.3

22.1

21.8

0.49

730

1769

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

701

1638

4.55

264.85

3.6

3.7

162.7

179.6

6.21

691

1570

(3033658) Prothrombin time (PT) actual/Normal

2375

11897

2.52

248.95

5.8

4.5

82.7

91.3

43.34

2334

11621

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2218

11000

2.49

234.72

2.5

2.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

653

1675

4.11

216.94

4.8

4.0

g/l

3.0

3.4

11.54

637

1598

(3044640) Blood type and Crossmatch panel - Blood

2592

14298

2.31

210.09

2.7

2.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

955

3253

3.18

205.91

2.3

ug/l

16.2

7.7

13.53

885

2887

(3022217) INR in Platelet poor plasma by Coagulation assay

1200

4761

2.79

196.01

44.8

20.3

inr

1.9

1.3

12.84

723

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3363

21563

2.13

177.12

4.2

4.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2273

12600

2.19

174.10

2.7

2.2

u/l

262.3

236.6

0.64

2182

11917

(3020779) Urea [Moles/volume] in Serum or Plasma

1067

4230

2.75

172.79

9.2

9.7

mmol/l

7.5

8.4

5.10

1039

4068

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1622

7885

2.35

170.14

4.7

3.4

ng/l

1454.8

576.5

4.88

1330

5581

(3013826) Glucose [Moles/volume] in Serum or Plasma

3922

26970

2.13

167.74

7.9

5.0

mmol/l

6.4

6.6

10.51

3744

25062

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

368

749

5.00

162.74

1.1

112.7

114.8

0.54

355

685

(4306422)

375

778

4.91

162.14

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

365

782

4.74

151.72

1.3

u/ml

4.4

4.6

0.08

176

361

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1466

7147

2.30

150.27

6.3

4.7

mmol/l

0.8

2.06

1395

6745

(3044889) 12 lead EKG panel

4217

30877

2.03

137.70

5.0

3.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

468

1298

3.70

137.55

9.5

4.5

u/ml

0.3

0.26

316

742

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

356

811

4.45

136.95

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

349

803

4.40

132.51

1.3

u/ml

3.5

4.2

0.30

124

287

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

130

12.97

132.49

7.9

7.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

122

14.16

130.87

7.0

7.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1033

4590

2.42

129.09

13.4

7.9

kpa

5.2

5.1

3.05

1001

4386

(3027801) Oxygen [Partial pressure] in Arterial blood

1033

4590

2.42

129.09

13.4

7.9

kpa

14.3

12.8

10.25

1001

4387

(3003396) Base excess in Arterial blood by calculation

1030

4576

2.42

128.72

13.4

7.9

mmol/l

1.0

0.9

0.18

854

3537

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

278

557

5.02

124.88

1.1

95.9

95.7

0.02

273

528

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2981

20125

1.84

115.88

10.9

7.0

mmol/l

1.2

26.50

2806

18477

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2411

15251

1.87

115.25

4.0

3.3

ng/l

57.3

86.1

0.39

1643

9346

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

900

3989

2.39

111.94

14.1

10.2

mmol/l

25.0

24.7

2.61

895

3971

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

591

2181

2.80

107.12

15.4

10.6

mmol/l

24.3

24.2

0.36

576

2064

(4268621)

254

541

4.70

105.98

2.5

2.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3151

22041

1.79

105.09

10.3

7.5

mmol/l

1.2

24.45

2725

18924

(3000991) Gas panel - Venous blood

966

4554

2.25

103.46

13.6

9.3

—

(3016502) Oxygen saturation in Arterial blood

895

4109

2.30

102.01

14.8

8.4

96.6

95.8

3.24

871

3958

(3019550) Sodium [Moles/volume] in Serum or Plasma

5671

48516

2.72

98.71

22.1

14.2

mmol/l

139.5

139.6

5.56

5601

47277

(3023103) Potassium [Moles/volume] in Serum or Plasma

5673

48672

2.69

95.63

22.1

14.3

mmol/l

4.0

2.85

5597

47306

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

38.45

93.53

4.9

6.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

639

2619

2.52

93.41

16.1

10.1

94.9

94.2

1.89

639

2608

(3002173) Hemoglobin [Mass/volume] in Arterial blood

825

3802

2.27

92.62

14.2

8.7

g/l

119.4

123.2

5.68

803

3666

(3014576) Chloride [Moles/volume] in Serum or Plasma

1049

5361

2.08

90.47

10.3

7.8

mmol/l

105.5

104.5

11.76

1037

5249

(3023368) Bacteria identified in Blood by Culture

1818

11276

1.80

87.00

5.0

4.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3145

22763

1.69

85.97

7.2

6.4

umol/l

14.7

12.2

10.03

2972

21540

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

942

4833

2.05

79.54

3.8

4.7

u/l

271.4

246.3

3.60

899

4591

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1158

6407

1.92

78.65

8.7

7.4

mmol/l

1.1

4.36

1111

6028

(3012544) pH of Venous blood

975

5089

2.02

78.41

6.8

5.8

7.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1102

6027

1.94

77.35

3.1

2.7

22.7

23.4

0.65

983

5281

(3014111) Lactate [Moles/volume] in Serum or Plasma

819

4030

2.12

77.18

13.8

8.2

mmol/l

1.3

1.4

1.03

788

3840

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

539

2229

2.47

76.76

19.3

10.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1160

6471

1.91

76.64

3.0

2.6

g/l

2.4

1.41

1095

6044

(3022948) Iron [Moles/volume] in Serum or Plasma

1238

7058

1.88

76.46

3.1

2.6

umol/l

13.3

13.7

1.06

1171

6610

(3024928) Oxygen saturation in Venous blood

306

973

3.15

71.82

6.5

6.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1614

10143

1.73

71.20

3.0

2.0

mg/l

1.2

0.37

1206

7544

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5614

49213

2.22

67.33

17.9

12.6

mg/l

25.7

22.7

9.36

4664

37816

(42870588) Differential panel, method unspecified - Blood

2422

17131

1.61

66.59

6.9

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

672

3270

2.11

64.58

6.8

6.7

mmol/l

23.9

0.02

641

3046

(3001604) Monocytes [#/volume] in Blood

3269

24923

1.58

64.51

7.0

6.6

e9/l

0.6

0.77

2843

21504

(3021447) Carbon dioxide [Partial pressure] in Venous blood

913

4979

1.91

63.55

6.4

5.9

kpa

5.9

5.8

0.70

893

4846

(3002032) Base excess in Venous blood by calculation

910

4966

1.91

63.19

6.6

5.9

mmol/l

1.5

1.7

1.14

773

3998

(3006315) Basophils [#/volume] in Blood

3270

25002

1.57

63.17

7.1

6.6

e9/l

0.0

0.68

2845

21574

(3034426) Prothrombin time (PT)

113

186

5.98

62.76

1.2

1.3

—

(3021589) Normoblasts [#/volume] in Blood

2980

22461

1.55

60.17

10.8

9.5

e9/l

0.0

0.55

2431

18241

(3013115) Eosinophils [#/volume] in Blood

3340

25864

1.55

59.37

7.5

7.0

e9/l

0.2

0.91

2941

22701

(3019198) Lymphocytes [#/volume] in Blood

3327

25744

1.55

59.32

7.1

6.6

e9/l

1.9

2.0

8.95

2938

22700

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5748

51280

2.33

58.98

20.0

14.1

umol/l

74.5

74.2

0.18

5748

51260

(3022096) Basophils/100 leukocytes in Blood

3004

22799

1.54

57.95

7.3

6.9

0.7

0.38

2866

21439

(40761511) CBC panel - Blood by Automated count

5741

51264

2.30

57.49

17.0

11.4

—

(3019069) Monocytes/100 leukocytes in Blood

3088

23615

1.54

57.26

7.5

7.1

8.7

8.5

4.95

2949

22282

(3024354) Oxygen [Partial pressure] in Venous blood

795

4283

1.92

56.99

6.3

5.6

kpa

5.0

4.9

1.04

778

4163

(3028626) Oxygen [Partial pressure] in Capillary blood

486

2196

2.24

56.02

10.7

7.1

kpa

9.2

9.3

0.23

473

2085

(3006504) Eosinophils/100 leukocytes in Blood

3062

23467

1.53

55.53

7.3

6.8

2.9

0.26

2909

22035

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

8.56

53.90

3.0

2.1

ug/g

171.2

166.3

0.08

(3024561) Albumin [Mass/volume] in Serum or Plasma

2527

18709

1.52

53.07

6.1

5.4

g/l

36.0

36.2

0.77

2369

17478

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

9.34

52.69

8.9

7.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

3142

24465

1.50

51.07

7.3

6.8

28.4

29.8

10.21

2990

22989

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

701

3750

1.91

51.02

9.2

5.9

mmol/l

1.8

1.2

5.14

553

2721

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1686

11512

1.58

50.51

2.7

2.4

mg/l

3.1

2.8

4.04

1501

9943

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

716

3874

1.89

50.30

9.2

5.8

kpa

5.1

0.92

690

3660

(3018010) Neutrophils/100 leukocytes in Blood

3100

24120

1.49

50.24

7.1

6.6

56.4

55.4

4.46

2963

22746

(3013650) Neutrophils [#/volume] in Blood by Automated count

3553

28424

1.50

50.20

9.5

e9/l

3.9

4.0

0.40

3107

24669

(3009343) pH of Capillary blood

711

3841

1.90

50.18

9.2

5.9

7.4

0.30

354

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4197

34773

1.53

50.07

8.0

7.3

u/l

83.4

81.2

1.73

4005

32890

(3003694) ABO and Rh group [Type] in Blood

2044

14592

1.53

50.07

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2176

15764

1.52

49.68

4.0

3.4

u/l

34.0

35.1

0.26

2089

15014

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1113

6882

1.69

49.65

2.0

1.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

199

610

3.23

49.57

8.9

7.1

mg/l

10.7

11.3

0.81

178

568

(3027945) Reticulocytes/100 erythrocytes in Blood

872

5047

1.78

49.20

3.7

3.4

1.7

0.48

810

4557

(3022313) Gas panel - Capillary blood

585

3002

1.98

47.99

9.3

6.2

—

(40758558) Short blood count panel - Blood

1832

12881

1.54

47.59

7.1

7.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

397

1778

2.24

46.57

9.8

10.2

mg/l

1.2

1.3

1.14

386

1695

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

557

2845

1.99

46.25

9.6

6.2

mmol/l

25.0

24.3

10.81

540

2738

(3002385) Erythrocyte distribution width [Ratio]

4904

42430

1.59

44.75

22.4

15.5

13.6

13.5

3.13

4848

41557

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

101

206

4.81

44.40

1.6

2.0

159.2

152.2

0.29

101

196

(3018418) pH of Serum or Plasma

1764

12459

1.52

44.20

4.3

4.1

7.4

0.05

390

2379

(3006576) Bicarbonate [Moles/volume] in Blood

154

5.47

43.79

9.2

6.6

mmol/l

25.6

24.4

2.44

140

(3004119) Hemoglobin [Mass/volume] in Venous blood

506

2568

1.99

42.69

6.4

4.8

g/l

127.2

130.7

2.58

494

2502

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

123

304

3.98

42.35

1.7

1.6

—

(3042936) Bacteria identified in Isolate by Culture

1008

6315

1.65

42.07

2.5

2.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

109

249

4.30

41.67

1.2

1.1

u/ml

12.1

22.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

118

290

4.00

40.95

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

176

4.95

40.58

1.1

81.7

91.4

1.63

(3019060) Gas panel - Arterial blood

497

2550

1.97

40.58

9.2

4.9

—

(3013512) EKG study

1636

11546

1.51

40.46

4.9

3.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

797

4745

1.72

40.17

2.0

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

802

4797

1.71

39.71

2.0

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

172

4.84

37.75

1.3

1.2

72.8

88.5

2.64

(3030467) Casts [#/volume] in Urine by Automated count

1789

13004

1.47

37.68

3.5

3.2

e6/l

0.4

0.80

1386

9691

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

120

5.70

37.35

1.2

1.1

79.8

75.9

0.20

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

120

5.62

36.27

1.2

64.4

67.0

0.12

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

234

4.15

36.23

1.0

1.1

93.8

95.7

0.26

185

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

402

1992

2.02

36.15

5.0

4.7

1.3

0.64

402

1979

(3018738) Hemoglobin F/Hemoglobin.total in Blood

6.55

36.14

3.9

4.0

4.7

0.15

(3013707) Erythrocyte sedimentation rate by Westergren method

4097

34710

1.43

36.04

4.4

4.0

mm/h

9.8

10.5

3.07

3860

32360

(3002582) Erythrocytes [#/volume] in Urine

1908

14157

1.44

35.63

3.6

3.4

e6/l

157.3

84.4

0.42

1489

10754

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

391

1941

2.02

34.96

5.0

4.7

0.7

0.75

386

1868

(36304419) Bacteria [Presence] in Urine

1749

12852

1.44

34.09

3.5

3.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2747

21859

1.39

33.95

3.4

2.9

ug/l

125.0

110.7

0.34

2576

20501

(3018095) Leukocytes [#/volume] in Urine

2180

16711

1.41

33.41

4.2

3.8

e6/l

71.1

80.9

0.23

1578

11573

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

289

1301

2.21

33.38

1.6

1.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

112

311

3.53

32.68

1.1

1.2

ratio

1.1

1.30

124

(3008152) Bicarbonate [Moles/volume] in Arterial blood

455

2443

1.87

32.22

13.3

6.9

mmol/l

25.0

24.4

3.47

430

2278

(3000850) Epithelial cells [#/volume] in Urine

1363

9663

1.47

31.67

3.0

2.7

e6/l

5.4

5.9

0.77

1195

8453

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

588

3439

1.73

31.21

3.2

2.5

ml/min/173m2

66.2

70.4

1.31

220

1280

(3011648) Oxygen content in Venous blood

131

424

3.04

29.87

6.7

9.9

11.4

11.3

0.08

131

424

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

359

1834

1.95

29.52

2.0

1.8

g/l

1.2

1.5

5.28

279

1591

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

830

5377

1.57

29.30

4.1

3.5

umol/l

8.4

7.3

1.00

736

4636

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

305

1490

2.03

28.47

3.6

2.5

ug/l

526.9

621.7

0.23

292

1395

(3023520) Reticulocytes [#/volume] in Blood

607

3681

1.66

28.04

3.6

3.0

e9/l

73.4

69.5

1.49

435

2691

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4874

43294

1.44

27.83

15.8

11.4

ml/min/173m2

87.4

0.01

4190

35055

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

709

4491

1.60

27.45

3.1

2.8

g/l

0.2

1.99

679

4225

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

259

1212

2.12

27.13

1.9

1.8

—

(3026782) Osmolality of Urine

1263

9079

1.44

26.64

3.0

2.8

mosm/kgh2o

560.0

559.4

0.03

1087

7748

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

256

1202

2.11

26.58

2.0

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4929

44035

1.43

25.78

4.9

4.4

mu/l

1.9

2.1

0.89

4610

40909

(3007461) Platelets [#/volume] in Blood

5949

55582

2.16

25.15

26.9

18.4

e9/l

244.8

255.4

31.44

5841

54097

(3026361) Erythrocytes [#/volume] in Blood

5951

55638

2.15

24.59

26.9

18.4

e12/l

4.5

4.6

20.73

5829

54017

(3035941) MCH [Entitic mass]

5950

55626

2.15

24.58

26.8

18.3

30.0

30.1

2.41

5902

54932

(3024731) MCV [Entitic volume]

5950

55627

2.15

24.56

26.8

18.3

90.0

0.32

5901

54932

(3010813) Leukocytes [#/volume] in Blood

5951

55659

2.14

24.21

26.9

18.4

e9/l

6.7

0.14

5833

54038

(3000963) Hemoglobin [Mass/volume] in Blood

5950

55653

2.13

24.08

27.4

18.5

g/l

133.9

136.7

37.45

5903

54957

(3051651) Icteric interference index of Serum or Plasma

105

344

2.99

23.52

4.4

4.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1112

7970

1.43

23.48

2.9

2.8

e6/l

1.0

0.32

657

4466

(3037467) Urinalysis macro (dipstick) panel - Urine

3748

32320

1.32

22.90

4.4

4.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3555

30442

1.31

22.81

4.6

4.1

e6/l

245.0

1406.3

2.91

380

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

190

850

2.20

22.34

1.6

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4229

37172

1.33

22.06

4.2

3.8

pmol/l

14.8

14.6

3.50

3906

34117

(3007853) Bacteria identified in Skin by Aerobe culture

826

5660

1.48

22.00

1.9

1.8

—

(3051593) INR in Capillary blood by Coagulation assay

147

4.05

21.88

7.3

10.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

655

4292

1.54

21.62

3.4

3.1

—

(44790048)

161

686

2.31

21.29

2.1

1.7

—

(44806118)

161

686

2.31

21.29

2.1

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

140

563

2.44

21.08

2.9

3.1

nmol/l

0.9

0.8

0.18

112

430

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

417

2467

1.68

21.03

1.7

1.6

—

(44790049)

160

686

2.29

20.86

2.1

1.7

—

(44790047)

160

686

2.29

20.86

2.1

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

193

894

2.13

20.81

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

268

1397

1.90

20.75

3.8

3.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

310

2.93

20.26

43.5

38.5

ug/l

7.6

7.1

1.64

285

(3009542) Hematocrit [Volume Fraction] of Blood

5173

47119

1.40

19.76

21.5

13.6

39.7

40.2

5.90

4108

36954

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

5.63

19.64

6.4

6.1

72.7

75.4

0.25

(3043409) Potassium [Moles/volume] in Arterial blood

234

1189

1.94

19.57

7.4

4.2

mmol/l

3.9

1.08

228

1115

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

166

746

2.19

19.35

1.8

1.7

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

293

2.94

19.23

2.7

2.5

umol/l

57.4

54.2

0.40

258

(44806071)

5.77

19.08

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

145

621

2.29

18.99

2.0

1.8

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

245

3.11

18.86

7.8

6.3

mg/l

97.2

65.3

2.05

191

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

282

1542

1.81

18.78

2.7

2.0

ug/l

2.3

2.4

0.03

252

1384

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.87

18.58

1.3

—

(3020891) Body temperature

297

1657

1.77

18.49

7.7

4.9

—

(3051611) Lipemic interference index of Serum or Plasma

123

496

2.43

18.46

4.4

3.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

728

5047

1.45

18.05

7.8

6.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1030

7588

1.38

18.05

3.1

3.0

e6/l

2.7

2.5

0.26

572

4095

(3015235) Bicarbonate [Moles/volume] in Capillary blood

224

1173

1.88

17.15

5.7

4.6

mmol/l

23.7

24.5

1.88

205

1038

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

833

2.04

16.90

1.8

1.5

—

(3012441) Differential panel - Pleural fluid

343

2.62

16.31

1.8

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5558

51589

1.46

16.19

11.8

9.7

u/l

27.1

27.4

0.24

5400

49970

(3015377) Calcium [Moles/volume] in Serum or Plasma

1780

14401

1.28

15.78

3.2

3.3

mmol/l

2.4

0.25

1566

12788

(3023183) Ammonium ion [Moles/volume] in Plasma

215

1146

1.85

15.60

3.9

3.1

umol/l

34.2

35.4

0.34

203

1007

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

112

3.91

15.54

7.0

mg/l

2.2

2.5

0.53

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1722

13906

1.28

15.42

2.9

2.6

u/l

58.8

57.5

0.43

1577

12916

(3042733) HLA Ab [Presence] in Serum

223

2.98

15.34

4.2

4.6

—

(3000494) Fungus identified in Specimen by Culture

760

5459

1.40

15.33

1.7

1.5

—

(3047181) Lactate [Moles/volume] in Blood

231

1277

1.78

14.88

12.2

6.0

mmol/l

1.2

1.3

0.77

208

1106

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

173

3.21

14.67

1.2

1.1

—

(3002256) Pathology report gross observation

769

5574

1.38

14.66

1.3

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

494

3308

1.49

14.55

5.8

4.8

ng/l

80.0

81.9

0.21

451

2956

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

457

3017

1.50

14.43

3.9

3.4

pmol/l

4.7

4.6

0.34

413

2728

(3028308) Erythrocytes [#/volume] in Pleural fluid

360

2.47

14.33

1.8

1.4

e6/l

56127.0

88270.5

0.53

212

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

497

3343

1.48

14.31

3.9

4.1

mmol/l

1.2

0.76

457

2927

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

233

1308

1.75

14.25

2.5

2.6

—

(3039000) Anion gap in Blood

172

881

1.92

14.14

14.6

7.2

mmol/l

10.4

11.5

4.52

155

782

(3018572) Chloride [Moles/volume] in Blood

172

882

1.91

14.10

14.6

7.2

mmol/l

106.0

105.3

1.15

155

783

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

268

1569

1.68

14.09

10.9

5.2

1.7

0.27

251

1456

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

199

1070

1.83

14.07

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

199

1070

1.83

14.07

1.5

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

408

2.32

13.37

1.8

1.4

e6/l

2170.9

2412.7

0.14

292

(3003338) MCHC [Mass/volume]

4826

44144

1.27

13.08

23.7

15.8

g/l

333.3

333.6

1.54

4797

43809

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

191

2.96

13.05

1.2

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

209

1170

1.76

12.94

9.9

7.1

iu/ml

686.4

657.5

0.04

167

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

139

684

1.99

12.88

1.6

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

101

440

2.24

12.84

1.7

1.5

g/l

30.8

33.7

1.58

396

(3027273) Bicarbonate [Moles/volume] in Venous blood

311

1937

1.58

12.79

4.9

3.9

mmol/l

25.3

25.1

0.59

305

1873

(3045788) Cell count panel - Pleural fluid

324

2.44

12.51

1.8

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

165

869

1.86

12.51

1.8

1.6

—

(3026008) Bacteria identified in Urine by Culture

1524

12386

1.25

12.44

3.0

2.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

471

3221

1.45

12.44

2.1

2.7

g/l

65.1

66.6

3.76

438

2978

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

266

1613

1.62

12.23

1.6

titre

87.5

321.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

122

586

2.04

12.11

1.7

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

182

1004

1.78

11.88

2.5

2.3

g/l

135.0

131.5

0.95

127

746

(3027315) Oxygen [Partial pressure] in Blood

185

1027

1.77

11.82

5.7

4.5

kpa

8.6

8.8

0.92

179

1011

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

130

645

1.97

11.80

1.6

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1171

9281

1.27

11.73

1.6

1.5

nmol/l

20.6

20.3

0.26

1032

8058

(3007930) Methemoglobin/Hemoglobin.total in Blood

257

1563

1.62

11.69

11.4

5.3

0.9

1.13

238

1454

(3009445) Proteinase 3 Ab [Units/volume] in Serum

307

1967

1.54

11.18

1.4

1.6

u/ml

9.2

14.0

—

(3012501) Base excess in Blood by calculation

181

1022

1.74

10.94

5.7

4.5

mmol/l

1.9

2.3

1.47

120

669

(3013290) Carbon dioxide [Partial pressure] in Blood

181

1023

1.74

10.90

5.7

4.6

kpa

5.1

5.0

0.55

175

1008

(3010375) cycloSPORINE [Mass/volume] in Blood

328

2.32

10.84

29.6

29.2

ug/l

138.6

125.1

0.74

284

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

155

2.95

10.61

2.6

umol/l

28.4

29.7

0.27

109

(1616796) Gas panel - Central venous blood

179

1019

1.72

10.52

5.0

3.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

371

2516

1.46

10.26

1.4

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

440

3080

1.41

10.23

1.8

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

165

928

1.74

10.14

7.3

5.3

u/ml

173.6

944.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

206

1241

1.63

9.80

2.0

1.7

u/ml

104.1

109.7

0.29

192

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

104

511

1.99

9.78

3.0

2.1

32.5

32.6

0.02

104

506

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4502

41260

1.21

9.75

5.2

5.1

mmol/mol

38.2

39.0

8.37

4237

38693

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

217

1329

1.60

9.65

2.0

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

559

4113

1.35

9.58

3.6

2.8

g/l

10.2

10.3

0.23

529

3801

(3024932) HLA-DR beta [Type]

226

2.50

9.56

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

180

1056

1.67

9.51

1.9

1.8

—

(3024471) HLA-A [Type]

227

2.49

9.48

1.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1371

11296

1.23

9.48

3.3

2.7

umol/l

3512.0

4084.5

0.22

1218

9997

(3021901) Oxygen saturation in Capillary blood

145

809

1.75

9.20

4.5

3.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

210

1293

1.59

9.16

1.3

1.4

iu/ml

7.9

14.8

—

(3037522) Nuclear Ab [Titer] in Serum

854

6701

1.27

9.11

1.4

titre

472.7

527.1

0.40

159

1308

(40767503) Oxygen content in Capillary blood by calculation

163

947

1.69

8.95

3.0

2.5

17.3

16.7

0.98

488

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

586

4410

1.32

8.60

2.5

u/l

35.8

47.6

0.53

512

3794

(40768804) Tissue Pathology biopsy report

2080

17952

1.18

8.59

2.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

443

3198

1.37

8.59

2.0

1.9

g/l

1.2

1.3

0.78

422

2969

(40760892) CBC W Ordered Manual Differential panel - Blood

1331

11035

1.21

8.53

4.9

4.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1328

11013

1.21

8.48

3.6

3.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

117

2.99

8.40

5.1

4.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

116

623

1.82

8.40

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

360

2.09

8.35

1.6

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

494

3649

1.34

8.25

1.2

1.3

u/ml

191.2

263.9

1.52

463

3386

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

119

650

1.79

8.17

1.3

—

(3010421) pH of Blood

194

1210

1.57

8.05

5.6

4.5

7.4

0.16

175

1007

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

261

1737

1.48

8.01

1.8

2.0

—

(3025159) Blasts/100 leukocytes in Blood

473

3493

1.34

7.92

4.3

4.6

0.6

0.2

0.27

117

835

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

218

2.37

7.85

1.3

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

899

7227

1.24

7.71

2.5

2.9

mmol/l

2.4

2.65

755

6304

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1403

11798

1.20

7.63

1.7

1.6

mmol/l

1.4

0.84

1198

10121

(3035350) Ketones [Presence] in Urine by Test strip

2602

23023

1.16

7.63

3.7

3.4

estimate

0.0

1.34

498

4253

(3019309) Folate [Moles/volume] in Red Blood Cells

864

6925

1.24

7.61

1.7

nmol/l

1182.4

1161.5

0.28

659

5308

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

102

545

1.83

7.56

1.7

1.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

2602

23038

1.16

7.53

5.0

4.7

estimate

0.0

0.50

521

4409

(3040893) Potassium [Moles/volume] in Capillary blood

5.66

7.52

3.9

3.3

mmol/l

4.4

4.6

0.52

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

237

1570

1.48

7.47

1.7

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1932

16724

1.17

7.45

2.0

1.9

pmol/l

94.4

96.3

1.10

1075

8955

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

121

688

1.72

7.27

2.6

2.5

—

(3017181) Myelocytes/100 leukocytes in Blood

508

3843

1.31

7.18

4.3

4.5

1.0

0.8

0.45

139

1061

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

191

1221

1.53

7.15

1.6

2.4

g/l

0.4

1.0

3.65

160

1077

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

4.10

7.11

1.2

1.7

16.5

7.7

0.54

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

218

1435

1.49

7.11

1.8

1.5

u/ml

251.8

242.0

0.21

148

822

(3000093) Morphology [Interpretation] in Blood Narrative

465

1.87

7.10

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

162

1000

1.58

7.08

1.4

2.3

g/l

0.0

0.00

141

933

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

173

1085

1.56

7.06

1.6

2.2

g/l

0.0

1.86

152

1013

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

190

1217

1.53

7.06

1.3

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

471

3536

1.31

7.04

4.0

4.2

0.8

0.5

1.09

109

775

(3021440) Promyelocytes/100 leukocytes in Blood

486

3667

1.31

7.01

4.3

4.6

0.2

0.1

0.40

130

983

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4721

43860

1.18

6.97

4.1

3.6

mmol/l

1.3

4.00

4435

40909

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

340

2.01

6.92

2.3

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

232

1558

1.46

6.85

1.3

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.12

6.83

1.4

—

(3003181) Sodium [Moles/volume] in Urine

129

760

1.66

6.82

1.8

mmol/l

78.2

67.7

1.38

104

623

(3009261) Glucose [Presence] in Urine by Test strip

2614

23266

1.15

6.82

3.7

3.4

estimate

0.0

1.96

507

4247

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

397

1.91

6.76

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

397

1.91

6.76

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

397

1.91

6.76

1.4

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

159

991

1.57

6.69

1.4

2.3

g/l

0.0

0.00

141

932

(3015171) Extractable nuclear Ab [Units/volume] in Serum

261

1802

1.42

6.65

1.3

1.2

u/ml

1.0

0.9

0.04

148

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

211

2.26

6.60

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3611

32933

1.15

6.55

3.6

3.2

u/l

46.6

44.5

0.98

3421

31144

(3020393) Adenovirus Ag [Presence] in Stool

189

2.32

6.43

1.8

—

(3035880) pH of Pleural fluid

177

2.36

6.42

1.3

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4746

44197

1.18

6.42

4.2

4.0

mmol/l

5.8

1.57

4388

40823

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

450

3406

1.30

6.36

2.2

2.3

au/ml

19.3

22.3

0.32

215

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

325

1.98

6.32

1.6

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

180

1169

1.51

6.31

1.8

2.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

127

2.60

6.23

1.5

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4897

45751

1.18

6.23

4.5

4.0

mmol/l

4.5

4.7

36.21

4637

43052

(3009871) Measles virus Ab [Titer] in Serum

180

2.32

6.20

1.5

1.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

220

1495

1.44

6.14

1.7

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

414

3116

1.31

6.10

1.2

1.3

au/ml

25.1

51.8

2.16

125

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

171

1107

1.51

6.10

1.4

2.2

g/l

38.0

0.00

145

973

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

526

1.74

6.05

2.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4946

46277

1.18

6.04

5.0

4.4

mmol/l

2.7

2.8

22.45

4665

43246

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

198

1327

1.46

5.96

1.7

2.3

g/l

3.0

3.1

0.52

155

1057

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

179

1176

1.49

5.96

2.3

1.9

iu/l

3.6

4.8

1.06

434

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4857

45401

1.17

5.88

4.5

4.0

mmol/l

1.4

3.82

4590

42523

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

288

2071

1.36

5.81

2.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

230

2.11

5.78

1.3

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1333

11401

1.17

5.73

1.6

1.5

g/l

2.2

0.25

842

6879

(3023419) Bacteria identified in Sputum by Culture

507

1.73

5.68

2.3

3.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

603

4800

1.24

5.63

2.5

2.3

nmol/l

360.1

365.8

0.28

560

4446

(3029937) Albumin [Presence] in Urine by Test strip

1420

12222

1.16

5.62

4.1

3.8

estimate

0.0

0.14

498

4240

(21494755) Public health laboratory ask at order entry panel

475

5703

0.79

5.61

1.3

—

(40768806) Pleura Pathology biopsy report

355

1.86

5.53

1.9

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

214

1481

1.41

5.45

1.7

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

499

1.72

5.45

1.9

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

191

1299

1.44

5.36

1.7

2.3

g/l

10.5

10.3

0.21

157

1124

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4029

37251

1.14

5.34

3.4

3.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

116

712

1.59

5.30

1.1

g/l

1.5

0.08

108

645

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

548

1.67

5.27

2.6

2.7

13.0

11.1

0.77

350

(40761535) Cells panel - Urine sediment

447

3468

1.27

5.23

3.6

3.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

256

1839

1.36

5.23

1.6

1.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.93

5.06

3.0

1.9

—

(3011985) Renin [Units/volume] in Plasma

104

630

1.61

5.04

1.4

1.6

mu/l

110.2

76.2

0.36

567

(3016038) Potassium [Moles/volume] in Urine

346

1.83

5.01

1.6

1.9

mmol/l

34.5

35.6

0.13

318

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

124

2.43

5.00

1.3

1.5

59.8

57.9

0.11

100

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

207

1449

1.40

4.97

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

522

1.66

4.91

5.0

5.3

mmol/l

6.2

7.1

3.69

435

(3037692) Legionella sp identified in Specimen by Organism specific culture

156

2.24

4.87

2.3

1.5

—

(3011412) CD3 cells [#/volume] in Blood

106

651

1.59

4.86

3.0

2.8

e9/l

1.1

1.3

1.45

402

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.31

4.80

1.5

1.2

—

(3042631) Mycobacterium sp identified in Specimen

511

1.66

4.78

3.0

2.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

228

1633

1.37

4.78

1.6

1.7

g/l

1.1

1.2

0.87

216

1553

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1403

1.39

4.76

1.7

2.3

g/l

3.7

3.8

0.47

150

1027

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1404

1.39

4.74

1.7

2.3

g/l

6.9

7.4

2.92

158

1080

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1404

1.39

4.74

1.7

2.3

—

(40768797) Stomach Pathology biopsy report

730

6034

1.19

4.67

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

131

852

1.50

4.67

1.2

—

(40761536) Microorganisms panel - Urine sediment

505

4027

1.23

4.66

3.6

3.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

207

1467

1.38

4.64

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

208

1478

1.38

4.59

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

161

2.17

4.54

7.4

7.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

453

1.68

4.50

1.1

1.3

titre

110.0

164.1

—

102

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.30

4.49

1.6

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

326

2485

1.29

4.44

1.8

2.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

263

1.89

4.39

1.6

1.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

377

1.73

4.34

3.4

2.9

umol/l

1.7

1.8

0.30

363

(3037121) Protein [Mass/volume] in Urine

240

1764

1.33

4.28

4.0

4.4

g/l

0.3

0.4

0.50

155

915

(3035637) Corticotropin [Mass/volume] in Plasma

126

829

1.48

4.28

1.8

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

812

6829

1.17

4.25

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

218

1585

1.34

4.19

1.6

1.7

g/l

0.2

0.71

206

1504

(3001964) Herpes simplex virus Ag [Presence] in Specimen

174

2.07

4.14

2.0

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

138

932

1.44

4.11

1.2

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

208

1.96

4.09

2.3

2.0

u/ml

412.4

20389.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

112

2.34

4.08

1.6

2.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

184

1310

1.37

4.06

1.5

1.4

ug/g

293.3

296.6

0.07

108

727

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

222

1.93

4.06

2.5

2.4

ng/l

134.3

144.7

0.22

181

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

512

1.60

4.05

1.7

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

323

2492

1.27

4.03

1.7

1.4

—

(40757373) Influenza virus identified in Isolate

2.51

4.02

2.0

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

178

1263

1.38

4.02

1.8

2.0

e6/l

11.6

22.3

0.85

134

958

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

178

1264

1.37

4.00

1.8

2.1

e6/l

349.6

3982.2

0.66

141

1010

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

132

2.21

3.97

1.8

2.1

e6/l

43753.4

17183.5

0.43

(3006245) CD3-CD19+ cells/100 cells in Blood

388

1.68

3.95

2.8

3.1

26.1

12.6

3.94

374

(3011544) Albumin [Mass/volume] in Pleural fluid

3.64

3.88

1.0

1.1

g/l

15.7

15.8

0.02

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2119

19100

1.11

3.84

2.8

2.4

nmol/l

75.3

74.4

0.84

1925

17568

(3000012) Reticulocyte production index

221

1.89

3.78

1.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

364

1.68

3.76

2.7

2.8

21.6

28.1

3.29

353

(3023511) Choriogonadotropin [Units/volume] in Urine

195

1420

1.34

3.75

1.3

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

3.03

3.71

1.1

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

192

1402

1.34

3.64

1.7

1.9

mg/l

428.7

493.9

2.10

182

1337

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

141

984

1.40

3.56

4.1

3.9

56.5

56.3

0.05

141

984

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

233

1.83

3.55

1.7

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

233

1.83

3.55

1.7

1.6

—

(3037756) Immunofixation for Serum or Plasma

106

702

1.47

3.55

1.3

1.7

—

(3045462) Protein/Creatinine [Ratio] in Urine

220

1.85

3.51

4.2

7.2

g/mol

1253.3

65.5

0.50

205

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

517

1.54

3.47

3.0

2.9

e6/l

464.3

565.7

1.02

406

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.43

3.46

2.0

1.8

mg/l

1.5

4.5

3.17

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.43

3.46

2.0

1.8

mg/l

1.1

1.2

0.15

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

138

966

1.39

3.43

1.2

u/ml

18.1

3.1

0.48

(3029075) Extractable nuclear Ab panel - Serum

188

1.91

3.40

1.0

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

598

1.50

3.39

3.0

2.8

44.5

44.3

0.01

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

173

1259

1.34

3.38

1.6

1.9

mmol/l

3.7

3.6

0.16

160

1185

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

446

3640

1.20

3.33

1.3

1.2

iu/ml

121.4

151.0

0.95

157

1301

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

507

1.54

3.33

3.1

3.0

e9/l

0.2

0.76

405

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

289

1.72

3.31

1.1

nmol/l

7.3

4.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

594

1.49

3.30

1.4

pmol/l

377.4

329.6

0.34

460

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

141

998

1.38

3.30

1.2

u/ml

20.4

41.2

1.58

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

341

1.65

3.29

3.8

3.0

umol/l

24.9

26.7

0.85

333

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

247

1.77

3.26

1.8

3.1

umol/l

294.5

175.7

0.52

144

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

177

1300

1.33

3.26

1.2

u/ml

1.1

37.6

—

(42870560) Thyrotropin [Units/volume] in Cord blood

372

1.62

3.26

1.0

mu/l

9.8

8.7

0.53

324

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

503

1.53

3.23

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

163

1187

1.34

3.19

1.2

1.3

u/ml

16.0

6.8

0.27

115

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

405

1.58

3.17

1.1

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.15

3.16

1.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

408

1.57

3.09

1.1

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

164

1204

1.33

3.06

1.2

1.3

u/ml

4.5

10.9

1.58

186

(3000060) B lymphocytes [#/volume] in Blood

341

1.62

3.05

2.8

3.0

e6/l

335.3

327.0

0.05

207

(3033705) Calcium.ionized [Moles/volume] in Venous blood

417

1.56

3.05

3.1

2.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

182

1.87

3.03

1.7

2.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

148

1.97

3.03

2.2

2.4

e6/l

26102.8

740.6

0.51

111

(3016018) Differential panel - Cerebral spinal fluid

638

1.45

3.02

2.0

2.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

3.00

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

434

1.55

3.00

3.0

2.3

mmol/l

4.0

1.16

427

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

225

1.77

3.00

1.6

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

225

1.77

3.00

1.6

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

225

1.77

3.00

1.6

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

225

1.77

3.00

1.6

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

176

1.88

2.99

1.6

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

176

1.88

2.99

1.6

2.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

123

868

1.38

2.97

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1374

12253

1.11

2.93

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

406

1.56

2.93

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

369

1.58

2.89

3.4

2.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

525

1.48

2.87

1.1

—

(3023410) Appearance of Cerebral spinal fluid

669

1.43

2.87

2.2

2.7

—

(3014891) Appearance of Pleural fluid

2.80

2.85

2.5

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

125

892

1.36

2.83

3.6

3.0

umol/l

14.2

8.2

1.47

101

679

(3035285) Chloride [Moles/volume] in Venous blood

433

1.53

2.82

3.0

2.3

mmol/l

105.8

105.4

0.36

426

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.28

2.77

1.6

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

113

797

1.38

2.76

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

405

1.54

2.74

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

179

1354

1.29

2.73

2.6

2.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

408

1.52

2.66

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

408

1.52

2.66

1.1

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

237

1861

1.24

2.65

1.3

—

(3049242) von Willebrand panel - Platelet poor plasma

4.85

2.65

1.0

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

136

996

1.33

2.63

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1411

12665

1.10

2.63

1.4

u/ml

1.5

2.2

1.24

356

3172

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

252

1.66

2.55

1.4

u/ml

16.4

19.7

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.29

2.53

7.6

7.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

305

1.59

2.53

1.2

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

613

1.41

2.53

1.0

1.1

—

3.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

688

1.39

2.50

1.6

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

615

1.41

2.49

1.1

1.3

u/ml

58.8

45.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

122

888

1.34

2.48

1.1

—

(3019174) dRVVT (LA screen)

2.57

2.46

1.1

1.2

—

(4010399)

382

3169

1.18

2.45

1.6

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.14

2.44

1.7

1.2

ug/l

96.1

124.3

—

(4035726)

447

3759

1.16

2.42

1.7

1.4

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.36

2.39

1.3

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

2.64

2.39

1.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1935

17690

1.09

2.38

3.9

3.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1055

9380

1.11

2.37

1.6

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

217

1713

1.24

2.35

1.3

—

(3021788) Differential panel - Synovial fluid

106

763

1.35

2.34

1.7

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

574

1.41

2.33

1.5

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

112

814

1.34

2.32

5.2

3.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

665

1.37

2.31

1.1

1.3

u/l

38.3

41.9

0.12

582

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

329

1.54

2.28

1.1

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

143

1.83

2.28

1.6

2.3

umol/l

18.1

16.7

0.31

143

(3030981) Hyaline casts [#/volume] in Urine by Automated count

271

2196

1.20

2.28

3.2

2.8

e6/l

0.2

0.39

263

2136

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

569

1.40

2.27

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

109

1.96

2.26

1.3

1.2

g/l

42.5

38.9

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

166

1.75

2.21

1.3

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

332

2753

1.18

2.17

2.0

2.3

u/l

4894.5

6257.5

0.40

111

1010

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

182

1.71

2.15

2.3

2.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.24

2.15

1.3

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.11

2.14

1.6

1.4

ng/l

163.0

55.9

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

288

1.55

2.14

1.9

2.6

u/ml

982.5

986.7

0.01

288

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.30

2.13

1.4

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

122

911

1.30

2.12

1.6

1.7

g/l

0.7

0.8

0.32

709

(3022229) Phosphate [Moles/volume] in Urine

154

1.76

2.12

3.0

2.9

mmol/l

23.5

19.7

0.58

143

(40768441) Liver Pathology biopsy report

375

1.48

2.11

1.6

1.5

—

(4062490)

603

1.37

2.09

1.6

1.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

4.15

2.09

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

628

1.36

2.09

1.4

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

424

1.44

2.08

1.3

1.2

u/l

159.2

86.0

0.44

296

(3004451) EKG impression Narrative

184

1.69

2.08

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

212

1698

1.22

2.04

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.98

2.03

6.1

6.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.98

2.03

5.0

6.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

339

1.49

2.03

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

234

1895

1.20

2.02

1.7

1.8

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

107

1.90

2.02

2.7

3.2

mg/l

44.9

22.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

128

1.82

2.01

1.5

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

128

1.82

2.01

1.5

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

599

1.36

2.01

1.6

1.4

g/l

0.4

0.24

436

(3044007) Cell count panel - Peritoneal fluid

121

1.84

2.01

1.9

2.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

157

1.73

2.00

2.2

2.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

600

1.36

1.99

1.6

1.4

g/l

7.6

6.5

1.25

439

(3028192) IgG subclass 2 [Mass/volume] in Serum

600

1.36

1.99

1.6

1.4

g/l

2.6

2.8

0.41

440

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

888

7898

1.10

1.99

1.2

1.3

iu/ml

22.0

29.2

1.78

232

2372

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.81

1.99

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

278

1.54

1.98

1.4

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

141

1084

1.27

1.98

1.6

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.62

1.97

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

101

1.92

1.97

1.3

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

502

4326

1.13

1.97

1.4

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

129

982

1.28

1.96

1.8

1.6

e6/l

10181.4

12537.8

0.53

706

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

174

1372

1.23

1.96

3.1

3.6

u/ml

780.7

1913.8

0.50

156

1181

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

151

1.73

1.95

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.73

1.92

1.0

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

160

1254

1.24

1.92

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

239

1951

1.19

1.91

1.6

1.9

u/l

38.0

39.3

0.46

209

1761

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

3.23

1.90

1.4

1.3

—

(3033799) Differential panel - Peritoneal fluid

131

1.78

1.89

2.6

2.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

550

1.36

1.85

3.7

4.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

176

1.65

1.84

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

154

1.70

1.84

2.6

2.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

627

1.33

1.82

1.6

1.3

nmol/l

0.6

0.18

603

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

162

1.68

1.81

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.08

1.81

1.0

—

(3049233) Organic acids panel - Urine

2.12

1.80

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.12

1.80

1.1

—

(3025941) Bacteria identified in Stool by Culture

339

2865

1.15

1.79

1.3

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

139

1082

1.25

1.79

1.1

au/ml

13.7

13.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.77

1.79

1.0

2.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.04

1.77

1.0

1.1

mmol/l

—

(3014271) Vancomycin [Susceptibility]

156

1.68

1.76

2.8

2.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

240

1.54

1.75

1.0

1.1

iu/ml

235.3

205.4

0.29

240

(3007566) Smooth muscle Ab [Titer] in Serum

176

1410

1.22

1.74

1.4

titre

83.8

102.5

0.32

133

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.09

1.74

1.6

1.9

ng/l

62.6

123.6

3.33

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

128

1.74

1.72

1.5

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

483

1.37

1.72

3.0

2.8

e6/l

621.4

730.8

0.52

148

(3010144) Erythrocytes [#/volume] in Synovial fluid

369

1.42

1.70

1.5

1.3

e6/l

186209.2

50395.1

0.62

260

(3023323) Follitropin [Units/volume] in Serum or Plasma

322

2732

1.15

1.63

2.0

1.5

iu/l

22.4

22.8

0.07

265

2209

(21494814) CD8 cells/100 lymphocytes in Specimen

198

1.57

1.63

2.5

2.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

199

1.56

1.60

1.2

1.1

u/l

10.8

23.6

2.82

153

(3009508) Creatinine [Moles/volume] in Urine

1527

14031

1.07

1.58

3.5

3.4

mmol/l

7.7

8.1

2.21

1332

12101

(3020961) Endomysium IgA Ab [Titer] in Serum

356

3050

1.14

1.58

1.2

titre

349.1

219.3

0.23

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

200

1.55

1.57

1.2

1.1

u/l

70.8

86.9

1.07

160

(3046861) Legionella sp Ag [Presence] in Urine

3.46

1.56

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

137

1084

1.23

1.56

2.6

3.4

mg/l

34.1

62.5

1.34

109

873

(4094501)

147

1172

1.22

1.56

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

773

6918

1.09

1.55

2.5

2.7

ug/g

143.9

125.7

0.45

606

5544

(3000492) Spirometry study

555

4888

1.11

1.55

1.6

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

308

3390

0.87

1.54

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

289

1.44

1.51

2.6

2.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

289

1.44

1.51

2.6

2.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

226

1.50

1.0

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1285

11759

1.07

1.49

2.0

—

(1761868) Lipid panel - Serum or Plasma

1725

17485

0.94

1.48

2.7

2.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

136

1083

1.22

1.47

2.5

3.4

mg/l

44.3

109.3

0.65

107

871

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

489

1.33

1.46

1.1

1.2

mg/l

29.1

41.5

3.49

401

(4015189)

1.81

1.46

1.9

2.5

—

(3038515) Glucose [Moles/volume] in Venous blood

736

1.27

1.46

4.8

3.1

mmol/l

6.5

7.4

3.12

715

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

797

7164

1.09

1.46

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

948

8584

1.08

1.45

1.6

pmol/l

25417649.5

30993858.7

0.11

779

7308

(3017569) Oxygen content in Arterial blood

181

1.55

1.45

1.8

2.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

106

1.74

1.44

1.6

1.5

nmol/l

24.0

14.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

576

1.30

1.42

1.6

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

253

2803

0.87

1.41

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.86

1.41

1.3

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

393

1.36

1.39

1.2

1.3

u/ml

2.5

1.0

0.45

142

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.42

1.39

1.0

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

115

1.69

1.37

1.5

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

252

2133

1.15

1.37

2.1

1.6

u/l

8.2

8.1

0.03

189

1631

(3008037) Lactate [Moles/volume] in Venous blood

102

795

1.25

1.37

4.7

3.0

mmol/l

1.4

1.6

1.86

102

769

(3032641) Amino acids panel - Urine

2.15

1.36

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

130

1043

1.21

1.34

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

455

1.32

1.33

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

472

5015

0.90

1.33

1.7

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

241

1.45

1.32

1.3

1.6

nmol/l

1.8

5.6

1.15

193

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.82

1.32

1.1

umol/24h

0.7

—

(4027681)

397

1.34

1.32

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

1.86

1.31

2.1

2.9

ml/dl

16.1

15.1

0.65

(3025018) Bordetella pertussis Ab [Titer] in Serum

473

1.31

1.2

—

(40768446) Kidney Pathology biopsy report

275

1.41

1.28

2.1

2.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

131

1057

1.20

1.28

2.5

3.4

ratio

1.3

2.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

129

1040

1.21

1.28

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

118

1.64

1.27

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.28

1.26

2.3

1.9

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.42

1.25

3.3

4.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

460

1.31

1.25

1.4

promille

1.1

1.4

0.71

353

(3004809) Band form neutrophils/100 leukocytes in Blood

701

1.25

1.24

3.3

3.6

1.6

1.3

0.38

550

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.69

1.24

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

221

1.45

1.22

1.4

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

242

2062

1.14

1.22

2.5

3.1

u/ml

157.9

50.6

0.42

235

1987

(3022145) Colonoscopy Study observation

554

4945

1.09

1.22

1.3

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.33

1.19

2.0

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

107

854

1.22

1.19

4.0

5.3

umol/l

374.6

384.6

0.32

761

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

207

1.45

1.18

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

199

1.46

1.18

1.1

1.2

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.55

1.17

1.2

1.1

—

0.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.55

1.17

1.4

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

224

1.43

1.16

1.1

ng/l

103.0

324.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

216

1.44

1.15

1.1

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

148

1222

1.18

1.15

1.5

2.0

mg/l

10.5

10.7

0.18

143

1145

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

779

1.22

1.14

1.7

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

177

1.48

1.13

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.34

1.12

1.3

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.90

1.12

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

423

3747

1.10

1.12

3.3

4.2

ug/l

7.0

23.0

3.02

326

2976

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

317

1.35

1.11

1.9

2.2

u/field

1.6

1.8

0.12

149

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

309

1.35

1.10

2.0

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

195

2151

0.87

1.08

1.6

1.9

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

497

1.27

1.08

1.1

iu/ml

7.4

8.8

0.17

113

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

236

1.40

1.07

1.7

1.6

u/field

1.4

3.6

1.50

179

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

472

1.27

1.07

1.9

2.1

mg/l

27.1

21.6

0.20

129

(3037556) Urate [Mass/volume] in Serum or Plasma

117

1.57

1.05

1.5

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

117

1.57

1.05

1.8

1.6

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.31

1.05

1.0

21.6

22.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.31

1.05

1.0

39.6

36.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

121

0.48

1.04

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

197

1.43

1.03

1.3

1.2

—

(3045716) Anion gap in Serum or Plasma

189

1.44

1.03

5.2

2.0

mmol/l

9.4

9.5

0.05

146

(40768443) Skin Pathology biopsy report

217

1862

1.13

1.03

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

110

1.59

1.03

5.9

2.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

108

878

1.19

1.03

1.8

2.0

—

9.3

—

(3025315) Body weight

2.06

1.02

3.4

2.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

305

1.34

1.02

1.0

1.1

u/l

1.0

1.1

0.51

149

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

433

1.28

1.01

1.3

1.4

umol/l

4.4

5.0

0.60

405

(3012516) Albumin [Mass/volume] in Urine

1269

11766

1.06

0.99

3.5

3.3

mg/l

353.4

325.1

0.08

837

7675

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.68

0.98

2.0

1.8

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

130

0.52

0.98

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.82

0.97

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

411

1.27

0.96

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

767

0.81

0.95

1.2

—

(40758292) HTLV I+II Ab panel - Serum

114

0.51

0.94

1.2

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1008

0.83

0.93

2.7

2.5

ug/min

88.7

112.4

0.32

655

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1121

0.84

0.91

2.4

2.2

nmol/l

0.9

0.8

1.00

946

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.15

0.91

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.15

0.91

1.8

3.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

106

1.55

0.91

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

106

1.55

0.91

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

286

1.32

0.91

2.4

3.0

umol/l

37.8

106.7

3.26

(3019225) pH of Specimen

439

3943

1.08

0.89

3.5

4.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

287

1.32

0.89

1.7

1.6

u/l

5.6

7.2

0.95

248

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

321

1.30

0.89

1.2

—

52.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.08

0.89

3.3

1.8

9.5

23.9

—

(3022670) pH of Venous cord blood

1.66

0.89

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

520

1.23

0.89

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

494

1.24

0.89

1.6

64.0

57.1

0.79

308

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

153

1686

0.88

1.7

1.6

iu/ml

4.5

3.9

0.04

360

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

107

1.54

0.88

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.00

0.87

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

683

7000

0.94

0.86

1.7

1.8

1.5

1.4

0.56

611

6257

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

105

869

1.17

0.86

1.5

1.4

ug/l

6.7

4.8

0.45

802

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.94

0.84

2.0

2.9

—

101.5

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

299

1.30

0.84

1.0

kpa

3.2

0.05

253

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.56

0.83

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

254

0.69

0.83

1.4

1.5

u/ml

2.7

9.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

231

0.67

0.83

1.7

1.9

ug/min

32.7

223.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

129

1430

0.87

0.83

1.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

792

1.18

0.82

1.4

u/l

21.1

21.4

0.03

674

(3007463) Buprenorphine [Presence] in Urine

1.88

0.81

1.7

4.6

—

(4146454)

419

0.76

0.81

3.1

2.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

301

1.29

0.80

2.7

34.1

40.7

1.44

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

110

1.50

0.80

1.1

1.2

pmol/l

426.1

297.9

0.45

(40768800) Prostate Pathology biopsy report

770

0.83

0.79

1.1

1.2

—

(3008898) HLA-B27 [Presence]

185

1997

0.89

0.79

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.78

0.0

4.4

—

(3019150) Specific gravity of Urine by Refractometry

1093

10164

1.05

0.78

4.2

3.7

kg/l

1.0

0.59

147

1539

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.52

0.78

1.2

—

42.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.52

0.78

1.2

—

26.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.67

0.78

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.78

0.0

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

303

1.28

0.77

1.0

kpa

7.1

7.3

0.34

256

(3004959) Base excess in Arterial cord blood by calculation

303

1.28

0.77

1.0

mmol/l

-1.8

-2.3

—

(3006598) pH of Arterial cord blood

303

1.28

0.77

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

283

0.72

0.77

1.5

1.4

mmol/l

5.2

5.6

1.56

269

(3045683) HLA typing for celiac disease panel - Blood or Tissue

371

0.76

0.77

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

210

1.34

0.76

3.1

3.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.71

0.75

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.71

0.75

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

115

1274

0.87

0.75

1.4

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

169

1.38

0.75

2.3

2.0

au/ml

310.0

129.9

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.11

0.75

1.2

1.0

—

0.1

—

(3027944) Amphetamines [Presence] in Urine

303

3174

0.92

0.72

1.8

2.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1314

12297

1.04

0.72

4.1

mg/mmol

22.0

9.8

0.45

859

8080

(40761539) Cells [Type] in Urine sediment by Light microscopy

113

1.46

0.72

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

316

1.26

0.71

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

580

0.82

0.70

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

484

0.80

0.70

1.5

1.6

mmol/l

7.5

7.6

0.03

301

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

163

1.37

0.70

1.1

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

335

3015

1.08

0.70

1.4

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1354

12691

1.04

0.69

3.3

3.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

378

1.23

0.69

1.8

1.5

22.8

32.7

1.32

231

(3008536) Aspergillus sp Ab [Presence] in Serum

114

1.45

0.69

1.6

2.4

—

(3002619) Bacteria identified in Specimen by Culture

106

1.46

0.69

1.3

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

386

0.78

0.69

10.6

13.3

nmol/l

807.5

801.8

0.03

371

(3004616) Nuclear Ab [Presence] in Serum

520

1.19

0.68

1.3

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

139

1.39

0.68

1.4

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

249

1.29

0.68

1.2

1.3

nmol/l

131.0

135.8

0.26

249

(3000764) Benzodiazepines [Presence] in Urine

308

3213

0.92

0.68

1.8

2.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

215

1.31

0.67

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

838

0.85

0.67

1.6

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

424

1.21

0.67

1.4

1.5

—

(3011288) Drugs identified in Urine by Screen method

202

2145

0.91

0.67

2.3

3.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

520

5322

0.94

0.66

1.8

—

(3015183) Erythrocyte sedimentation rate

285

0.75

0.66

1.1

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

242

1.28

0.65

1.5

1.1

u/l

21.5

23.8

0.15

205

(3013166) Neutrophils/100 leukocytes in Synovial fluid

124

1.41

0.65

1.8

1.3

54.5

51.5

0.11

108

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.62

0.65

10.0

11.0

mmol/l

4.5

6.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

234

1.28

0.64

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.58

0.64

1.1

1.3

umol/24h

1.6

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

260

1.27

0.64

1.1

miu/ml

1419.8

1459.5

0.08

260

(4034850)

162

1418

1.11

0.63

12.5

8.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

385

1.21

0.61

3.6

4.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

144

1545

0.90

0.60

1.5

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

109

937

1.13

0.59

1.1

—

(21494434) Karyotype in Bone marrow

404

1.20

0.59

1.2

—

(3008295) Osmolality of Serum or Plasma

565

1.17

0.59

1.5

1.6

mosm/kgh2o

284.8

284.6

0.02

428

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

351

1.22

0.59

1.1

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

180

0.70

0.59

1.0

1.2

u/ml

2.3

5.7

1.03

155

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

1.0

—

(3028300) Cannabinoids [Presence] in Urine

313

3240

0.93

0.59

1.9

2.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.52

0.58

1.1

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

169

1.32

0.58

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

197

2077

0.92

0.58

1.6

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.44

0.58

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.52

0.58

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

927

0.88

0.57

1.0

1.1

u/ml

1.0

0.4

0.37

290

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

310

3205

0.93

0.57

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

170

1.31

0.57

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

442

1.18

0.56

1.2

1.4

mmol/l

10.7

11.6

0.32

110

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

844

7873

1.04

0.56

2.8

ug/l

0.7

0.15

520

4878

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1435

13527

1.04

0.56

4.4

ug/l

1.8

2.4

4.28

1262

12285

(3027008) Opiates [Presence] in Urine

313

3233

0.93

0.56

1.8

2.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

179

1.30

0.56

3.2

2.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

240

1.25

0.55

1.4

—

(3019977) pH of Arterial blood

214

1.27

0.55

3.4

2.5

7.4

1.54

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

544

5027

1.05

0.54

4.2

4.1

33.1

31.7

2.10

399

3546

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

350

0.80

0.54

1.8

1.9

—

(40768793) Breast Pathology biopsy report

860

0.88

0.53

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.53

0.52

2.2

1.6

umol/l

33.2

44.3

—

(3032057) Clostridioides difficile [Presence] in Stool

1.45

0.52

1.9

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

106

919

1.12

0.52

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

291

3003

0.94

0.52

1.8

2.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

348

1.20

0.52

1.1

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

470

4335

1.05

0.51

2.5

2.2

nmol/l

12.5

12.8

0.31

420

3833

(3013727) Leukocytes other/100 leukocytes in Blood

156

1.30

0.51

3.6

4.4

48.9

49.9

0.07

151

(36660697) Celiac disease serology panel - Serum

520

4810

1.05

0.51

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

182

1.28

0.51

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

182

1.28

0.51

1.5

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

252

1.23

0.50

1.5

1.1

u/l

127.1

107.3

0.15

217

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

192

2009

0.92

0.50

1.6

1.7

mg/l

4.7

4.0

0.28

130

1371

(40760888) Immunoglobulin light chains.free panel - Serum

830

1.12

0.50

2.9

3.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

235

1.24

0.49

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

224

2022

1.08

0.49

3.5

3.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

360

1.19

0.48

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

172

0.73

0.47

1.2

u/ml

5.5

10.7

0.57

153

(3044941) Cell count panel - Synovial fluid

669

1.13

0.47

1.7

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.47

0.47

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

138

0.70

0.46

1.0

1.2

—

(3022689) Creatine [Moles/volume] in Urine

138

0.70

0.46

1.3

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

470

1.16

0.46

1.4

1.3

pmol/l

72.0

130.4

0.43

146

(3020650) Glucose [Presence] in Urine

133

1.31

0.46

1.2

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

310

0.81

0.45

1.2

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

668

6704

0.96

0.44

1.8

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

117

1034

1.10

0.43

2.3

2.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

201

0.77

0.43

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.61

0.43

11.4

3.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

135

1.29

0.42

1.2

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

205

1.23

0.42

1.3

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

401

0.84

0.42

2.6

3.1

mg/l

37.2

60.4

0.34

299

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

198

1793

1.07

0.42

1.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

189

0.77

0.41

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.51

0.41

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.35

0.41

2.0

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

337

0.83

0.41

1.9

2.1

—

(3012565) Volume of 24 hour Urine

224

1.21

0.40

2.3

2.4

2069.8

2057.1

0.03

204

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

326

0.83

0.40

1.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

513

1.13

0.40

1.9

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.47

0.40

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

168

1516

1.08

0.40

1.5

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

100

0.68

0.39

6.6

4.8

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

102

0.66

0.39

1.0

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

524

1.13

0.38

1.7

1.4

iu/ml

30.0

22.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

114

1201

0.92

0.38

1.5

1.8

—

(3045414) Leukocytes [Presence] in Urine

223

2036

1.06

0.38

1.9

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.36

0.38

1.7

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.36

0.38

3.0

2.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

217

1.21

0.38

2.6

mg/l

8.7

9.7

0.42

188

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

937

0.91

0.37

1.2

1.1

iu/ml

72.6

9536.3

0.54

248

(3017354) Segmented neutrophils/100 leukocytes in Blood

407

1.14

0.37

3.1

3.7

64.4

56.5

1.78

259

(3017704) Immunofixation for Urine

191

1.22

0.37

1.5

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.37

0.37

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

787

7839

0.97

0.36

2.0

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

248

2533

0.95

0.36

1.9

2.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.28

0.36

1.6

1.7

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

254

1.18

0.36

1.4

1.6

—

1298222.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

263

1.18

0.36

1.8

1.6

u/l

9.6

5.3

0.68

135

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

100

888

1.09

0.36

1.6

1.5

nmol/l

0.4

0.20

712

(3052592) Norovirus Ag [Presence] in Stool

1.38

0.36

1.1

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.34

0.36

2.3

2.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.26

0.36

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

372

1.15

0.36

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

372

1.15

0.36

1.9

2.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.45

0.36

1.5

1.4

umol/24h

269.2

305.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.45

0.36

1.0

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

903

0.91

0.35

1.1

u/ml

2.9

3.8

0.33

410

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

201

1.21

0.35

1.2

g/l

0.3

0.12

161

(3034891) Synovial lining cells/100 cells in Synovial fluid

201

1.21

0.35

1.6

1.4

2.0

4.3

—

(1002224) Polysomnography panel

232

2128

1.06

0.35

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

104

927

1.09

0.35

4.6

3.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

175

1.22

0.34

5.0

4.6

—

(3004775) Volume in Urine collected for unspecified duration

330

0.85

0.34

2.5

2.3

654.7

625.2

0.20

234

(3036603) Volume of Urine

292

1.16

0.34

1.4

1.5

1738.0

2074.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

183

0.79

0.34

2.1

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

114

1.28

0.33

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

167

1.22

0.33

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

318

0.85

0.33

1.2

1.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.29

0.32

1.2

—

(3017509) Phencyclidine [Presence] in Urine

1.35

0.31

1.2

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

141

1280

1.07

0.31

2.1

1.9

pmol/l

199.1

199.6

0.02

136

1210

(3017732) Neutrophils [#/volume] in Blood

358

3335

1.04

0.31

2.7

e9/l

4.1

0.01

293

2731

(3005570) Glucose [Moles/volume] in Urine

432

1.12

0.31

2.0

—

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

787

7435

1.03

0.31

1.3

1.2

u/ml

9.5

10.8

0.21

295

2928

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

439

0.88

0.31

1.7

2.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

984

0.92

0.30

3.8

3.2

mg/l

24.9

24.8

0.01

587

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

134

1.23

0.29

1.9

1.6

—

(4198724)

407

1.12

0.29

1.3

2.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

759

7527

0.97

0.28

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

257

2384

1.05

0.28

1.6

mu/l

351.1

307.9

0.77

238

2164

(3026389) Candida sp identified in Specimen by Organism specific culture

649

1.09

0.28

1.2

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

115

0.76

0.27

1.4

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

172

1754

0.95

0.27

1.4

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

136

1.21

0.26

1.2

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.28

0.26

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.28

0.26

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.70

0.26

1.2

—

8.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

165

0.82

0.25

1.1

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

994

0.93

0.25

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.18

0.24

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

400

0.90

0.24

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

275

2568

1.04

0.24

1.1

u/ml

3.3

14.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1130

10770

1.02

0.23

4.0

3.8

22.7

21.6

1.26

497

4754

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.24

0.22

1.0

1.1

—

5.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

277

1.12

0.21

7.2

6.8

—

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

5.8

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

109

1115

0.95

0.21

1.1

u/ml

7.1

5.2

0.40

523

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.2

—

(3020491) Glucose [Moles/volume] in Blood

361

1.10

0.21

2.0

1.8

mmol/l

6.7

6.4

0.19

262

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.20

0.0

2.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

269

1.12

0.20

1.0

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

108

0.81

0.20

1.0

—

(4133840)

141

1.17

0.19

1.3

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.19

0.19

3.3

2.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

691

1.07

0.19

1.3

1.4

mmol/l

7.3

7.1

0.19

504

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

224

1.12

0.19

1.0

1.1

u/ml

5.0

8.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

472

0.92

0.18

1.0

1.1

u/ml

0.3

1.6

—

108

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.20

0.17

1.0

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.15

0.17

1.1

u/ml

0.6

3.1

—

(44813793)

441

1.08

0.17

1.0

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.72

0.17

1.0

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.17

0.16

1.0

u/ml

0.1

3.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

348

1.09

0.16

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

874

8580

0.98

0.16

2.1

2.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

135

1.15

0.15

1.3

1.4

ug/l

10.8

8.6

0.66

135

(3044927) Protein electrophoresis panel - Urine

349

1.08

0.15

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

468

0.93

0.15

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

209

1.11

0.15

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

670

1.06

0.15

1.8

—

(3030313) Adrenal Ab [Titer] in Serum

1.15

0.15

2.0

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

537

0.94

0.15

1.1

1.3

u/ml

4.5

11.6

0.74

249

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

435

1.07

0.14

1.0

1.1

mg/l

302.0

285.5

0.55

397

(40761995) Spermatozoa Progressive [#/volume] in Semen

210

1.11

0.14

3.6

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

210

1.11

0.14

7.3

5.8

—

(4211845)

236

0.90

0.14

3.8

3.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

352

1.07

0.13

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

352

1.07

0.13

1.5

—

(3016750) Collection duration of Urine

255

0.91

0.13

2.7

2.3

min

490.8

489.6

0.02

195

(3012494) Peanut IgE Ab [Units/volume] in Serum

343

1.07

0.13

1.1

1.2

u/ml

4.5

19.2

0.90

249

(3025130) Human papilloma virus identified in Specimen

627

1.05

0.13

1.6

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

120

1122

1.04

0.13

1.6

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

118

1103

1.04

0.13

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

151

1507

0.97

0.12

1.0

1.1

u/ml

1.1

0.04

829

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

344

1.07

0.12

1.1

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

101

1.15

0.12

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

101

1.15

0.12

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

101

1.15

0.12

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

101

1.15

0.12

1.3

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

130

1299

0.97

0.12

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

341

3362

0.98

0.11

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

422

0.94

0.11

1.1

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

129

1.13

0.11

1.0

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

1.13

0.11

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

103

1032

0.97

0.11

1.0

1.1

u/ml

6.7

7.1

0.07

501

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

412

1.06

0.11

2.1

2.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

148

1473

0.97

0.11

1.1

u/ml

2.8

3.2

0.11

433

(3005033) Fetal Nuchal fold Thickness US

130

1296

0.97

0.10

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

121

1.12

0.10

4.3

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

121

1.12

0.10

4.3

2.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.08

0.09

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.08

0.09

1.4

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

163

1615

0.98

0.09

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

163

1614

0.98

0.09

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.12

0.09

2.0

2.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

157

1554

0.98

0.08

1.0

1.1

u/ml

5.9

6.0

0.03

964

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

204

1940

1.02

0.08

1.3

miu/ml

219.2

219.0

0.00

913

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.77

0.08

15.2

9.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

248

0.94

0.07

1.1

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

163

1609

0.98

0.07

1.4

—

(3042517) Benzodiazepines panel - Urine

0.86

0.07

3.1

2.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.86

0.07

1.3

1.1

ug/l

74.3

72.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.83

0.07

2.0

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

179

1704

1.02

0.07

1.1

1.2

u/ml

3.4

2.1

0.47

883

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.88

0.06

1.1

1.9

ug/l

1.9

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.90

0.06

1.2

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

511

0.97

0.06

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

153

1.08

0.06

4.5

3.2

—

(3025577) Chromium [Mass/volume] in Blood

226

0.94

0.06

2.2

2.0

ug/l

2.9

2.1

0.39

194

(3043238) Trisomy 21 risk [Likelihood] in Fetus

135

1330

0.98

0.05

1.4

1.5

—

(3048879) Bone marrow aspiration report

106

1.10

0.05

1.8

2.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

164

1612

0.98

0.05

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

215

0.95

0.05

2.5

2.3

mmol/l

0.9

1.9

1.33

164

(3024522) Salmonella sp identified in Specimen by Organism specific culture

548

0.97

0.05

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.10

0.04

1.9

2.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

558

1.02

0.04

1.2

1.3

u/ml

1.4

3.7

1.72

284

(3028707) Methadone [Presence] in Urine by Screen method

149

1425

1.01

0.04

2.3

2.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

414

3984

1.01

0.04

2.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

555

0.98

0.03

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

545

0.98

0.03

1.5

—

(4024509)

379

0.97

0.03

1.3

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

315

3030

1.01

0.03

1.2

—

(3047189) Immunofixation for 24 hour Urine

175

1.05

0.03

1.5

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

162

1585

0.99

0.03

1.4

1.5

—

(3045142) Bone marrow Pathology biopsy report

531

1.02

0.03

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

144

0.94

0.03

1.0

1.5

nmol/l

111.7

133.0

—

106

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

493

1.02

0.03

5.1

4.5

u/ml

46.1

99.1

1.21

149

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

504

4902

1.00

0.03

2.2

2.1

—

(3022621) pH of Urine by Test strip

295

2874

0.99

0.02

3.0

2.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

163

0.95

0.02

2.0

3.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

832

1.01

0.02

1.1

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

328

0.97

0.02

1.8

2.0

mg/l

3.4

4.2

0.82

316

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

163

1567

1.01

0.02

1.1

u/ml

4.5

7.0

0.36

219

(4281824)

395

0.98

0.01

1.3

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

100

977

0.99

0.01

1.4

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

332

1.02

0.01

2.4

2.8

—

21.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

200

0.97

0.01

1.3

2.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

536

1.01

0.00

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

229

1.02

0.00

1.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

271

1.00

0.00

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

213

1.00

0.00

3.8

3.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

540

1.00

0.00

1.5

—

(3045424) Erythrocytes [Presence] in Urine

770

1.01

0.00

1.4

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

110

0.97

0.00

1.0

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

538

1.01

0.00

1.5

—

(3024263) Appearance of Synovial fluid

221

1.01

0.00

1.7

1.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

295

1.02

0.00

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

101

0.96

0.00

1.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

493

1.00

0.00

1.5

1.3

—

38.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.1

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

16.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.98

0.00

1.7

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.87

0.00

2.5

8.1

—

(4038314)

0.95

0.00

1.4

1.2

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.88

0.00

2.7

2.9

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

3.2

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

1.8

—

(3000285) Sodium [Moles/volume] in Blood

0.88

0.00

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.90

0.00

8.3

6.8

—

(3002022) Protein C Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.2

—

57.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

34.9

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.95

0.00

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

2.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

123.2

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CONGEN_MALFO_CIRCULATO_SYSTEM and mortality.

Females

Parameter	HR [95% CI]	p-value
Q17_CONGEN_MALFO_CIRCULATO_SYSTEM	1.932 [1.68, 2.22]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.025

During the follow-up period (1.1.1998 — 31.12.2019), 1526 out of 29516 females with Q17_CONGEN_MALFO_CIRCULATO_SYSTEM died.

Males

Parameter	HR [95% CI]	p-value
Q17_CONGEN_MALFO_CIRCULATO_SYSTEM	1.689 [1.46, 1.95]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1702 out of 28904 males with Q17_CONGEN_MALFO_CIRCULATO_SYSTEM died.

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_MALFO_CIRCULATO_SYSTEM.

N-year risk	Females	Males
1	0.146%	0.286%
5	0.941%	1.842%
10	2.405%	4.59%
15	4.765%	8.55%
20	8.324%	14.633%

Relationships between endpoints

↥

Index endpoint: Q17_CONGEN_MALFO_CIRCULATO_SYSTEM – Congenital malformations of the circulatory system

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Congenital malformations of the circulatory system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints